Clinical Trials Browser

Phase 2 × Peripheral Blood Stem Cell Transplantation × Tumor-Agnostic × Clear all

NCT01525407 2017-08-17

Donor Atorvastatin Treatment for Preventing Severe Acute Graft-Versus-Host Disease in Patients Undergoing Myeloablative Peripheral Blood Stem Cell Transplantation

Phase 2 Completed

83 enrolled 16 charts

Neoplasms